glp-1's The Latest on GLP-1s | Lexington Medical Center Blog GLP-1 Receptor Agonists as Treatments

Repurposing antidiabetic drugs like GLP-1 mimetics for neurological diseases is gaining interest, as metabolic disorders pose a significant risk for neurodegeneration

You can also object to the use of your data for direct marketing

If not, the dose is likely too low

Media and Third-Party Validation Major issues Mochi Health displays media logos on its website without links to the actual articles

[4] Practical guidance for patients and healthcare professionals: GLP-1 receptor agonists should be prescribed according to their licensed indications (type 2 diabetes and, for specific agents, weight management) Patients with diabetes and cognitive concerns should ensure optimal management of all cardiovascular risk factors, including blood pressure, cholesterol, and glycaemic control Lifestyle interventionsincluding regular physical activity, Mediterranean-style diet, cognitive engagement, and social interactionremain the most evidence-based approaches to reducing dementia risk Anyone experiencing memory problems, confusion, or cognitive changes should contact their GP for proper assessment and potential referral to a memory clinic Seek urgent medical attention for sudden confusion, rapidly worsening symptoms, stroke-like symptoms, or cognitive changes following head injury Patients should not discontinue or commence GLP-1 receptor agonists based solely on potential cognitive effects without medical consultation The field of GLP-1 research in neurodegeneration represents an exciting area of investigation, but clinical recommendations must await robust trial evidence demonstrating clear benefit and acceptable safety profiles in relevant populations